- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 18 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 15 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.2: 2 residues within 4Å:- Chain A: N.691, Q.1045
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.3: 3 residues within 4Å:- Chain A: N.254, N.256
- Chain C: K.532
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.4: 7 residues within 4Å:- Chain A: F.316, N.317, A.346
- Chain C: L.429, F.430, Y.463, Q.467
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:Y.463
NAG-NAG-BMA-MAN-MAN.5: 4 residues within 4Å:- Chain A: N.775, S.777, Q.778, N.902
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.9: 1 residues within 4Å:- Chain A: N.1108
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.13: 2 residues within 4Å:- Chain B: N.691, Q.1045
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.14: 3 residues within 4Å:- Chain A: K.532
- Chain B: N.254, N.256
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.15: 7 residues within 4Å:- Chain A: L.429, F.430, Y.463, Q.467
- Chain B: F.316, N.317, A.346
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:Y.463
NAG-NAG-BMA-MAN-MAN.16: 3 residues within 4Å:- Chain B: N.775, S.777, Q.778
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.20: 1 residues within 4Å:- Chain B: N.1108
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.24: 3 residues within 4Å:- Chain C: N.691, L.896, Q.1045
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:L.896
NAG-NAG-BMA-MAN-MAN.25: 3 residues within 4Å:- Chain B: K.532
- Chain C: N.254, N.256
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.26: 7 residues within 4Å:- Chain B: L.429, F.430, Y.463, Q.467
- Chain C: F.316, N.317, A.346
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:Y.463
NAG-NAG-BMA-MAN-MAN.27: 3 residues within 4Å:- Chain C: N.775, S.777, Q.778
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.31: 1 residues within 4Å:- Chain C: N.1108
No protein-ligand interaction detected (PLIP)- 15 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.34: 2 residues within 4Å:- Chain A: N.683, N.684
Ligand excluded by PLIPNAG.35: 4 residues within 4Å:- Chain A: V.282, E.283, T.576, N.577
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain A: E.106, N.138, N.139
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain A: Y.2, N.35
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain A: T.82, N.208, T.210
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain B: N.683
- Chain C: I.768
Ligand excluded by PLIPNAG.40: 4 residues within 4Å:- Chain B: V.282, E.283, T.576, N.577
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain B: N.138, N.139
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain B: Y.2, N.35
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain B: T.82, N.208, T.210
Ligand excluded by PLIPNAG.44: 1 residues within 4Å:- Chain C: N.683
Ligand excluded by PLIPNAG.45: 4 residues within 4Å:- Chain C: V.282, E.283, T.576, N.577
Ligand excluded by PLIPNAG.46: 2 residues within 4Å:- Chain C: N.138, N.139
Ligand excluded by PLIPNAG.47: 2 residues within 4Å:- Chain C: Y.2, N.35
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain C: T.82, N.208, T.210
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Williams, J.A. et al., Structural and computational design of a SARS-CoV-2 spike antigen with improved expression and immunogenicity. Sci Adv (2023)
- Release Date
- 2023-06-21
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 18 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 15 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 15 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Williams, J.A. et al., Structural and computational design of a SARS-CoV-2 spike antigen with improved expression and immunogenicity. Sci Adv (2023)
- Release Date
- 2023-06-21
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C